Lotemax Gel
Product Images NDC 24208-503

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lotemax (NDC 24208-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Loteprednol Etabonate Structural Formula (9a666065 D467 42b8 8ecd 0ec1de9986d5 01)

Chemical structure of loteprednol etabonate, the active ingredient in LOTEMAX ophthalmic gel 5 mg/g, showing detailed molecular bonds and groups along with its molecular weight of 466.96.*

FDA Label Image

Carton

LOTEMAX loteprednol etabonate ophthalmic gel 0.5% (5 mg/g) packaging label from Bausch & Lomb Incorporated. The label includes dosage form as gel for ophthalmic use, 5 g net weight, storage instructions, and barcodes. It also notes prescription use, loteprednol etabonate as the active ingredient, preservatives, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.